Skip to content
Men Under Microscope – Lifestyle
Home
Sample Page
Author:
SOTIO Biotech B.V.
FDA Grants Fast Track Designation to SOTIO’s SOT109, a CDH17-targeting ADC for Colorectal Cancer
July 14, 2026
SOTIO Receives U.S. FDA Orphan Drug Designation for SOT106, a Potential Best-in-Class ADC for Sarcoma
June 3, 2026